Abstract
Compounding Pearls -- Wound Care: Drugs and Formulations for Dermal Healing, Part 2
Author(s): Riepl Mike
Issue: Jul/Aug 2021 - Volume 25, Number 4
Page(s): 282-287
Abstract
Diseases of and injuries to the human skin have been recognized since antiquity as health hazards that can increase morbidity and mortality and greatly compromise quality of life. The earliest effective treatments for such conditions and disorders were compounded, as were all ancient medicaments, to accommodate individual patient sensitivities and responses to therapy. That tradition continues today in precision pharmaceutical compounding, which is an essential component in a triad of medical and pharmaceutical care that actively involves physicians, pharmacists, and patients. To ensure a good therapeutic outcome, compounders must be acutely aware of drug compatibilities and adverse interactions. Those topics are addressed in this second article in a series on agents that, when effectively compounded, promote dermal healing when conventional therapies fail to do so or cannot be tolerated by the patient. Misoprostol, gabapentin, ketamine, and aloe vera are described in that regard. Formulations that are, at the time of this writing, unavailable in the literature are also provided.
Related Keywords
- skin disorders
- dermal injury
- formulations
- topical preparations
- misoprostol
- prostaglandin E analog
- anti-inflammatory agent
- inflammation
- collagen formation
- gabapentin
- calcium 2+ channel inhibitor
- skin itching
- pruritus
- wound pain
- ketamine
- aloe vera
- wound healing
Related Categories
- DERMATOLOGY
- FORMULATIONS
- WOUND CARE
- DOSAGE FORMS/DRUG CARRIERS
Related Articles from IJPC
Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
---|---|
Jul/Aug 2021
Pg. 282-287
|
Author(s):
Riepl Mike
|
Jul/Aug 2004
Pg. 269-274
|
Author(s):
Helmke Christopher D
|
Nov/Dec 2022
Pg. 480-488
|
Author(s):
Riepl Mike
|
Mar/Apr 2021
Pg. 100-103
|
Author(s):
Riepl Mike
|
Sep/Oct 2021
Pg. 372-377
|
Author(s):
Riepl Mike
|
Nov/Dec 2021
Pg. 468-472
|
Author(s):
Riepl Mike
|
Jul/Aug 2020
Pg. 278-281
|
Author(s):
Riepl Mike
|
Jul/Aug 2020
Pg. 282-285
|
Author(s):
Riepl Mike
|
Mar/Apr 2002
Pg. 92-95
|
Author(s):
Kincaid Michele R
|
Mar/Apr 2004
Pg. 101-105
|
|
Mar/Apr 2022
Pg. 94-98
|
Author(s):
Riepl Mike
|
Nov/Dec 1999
Pg. 496-500
|
Author(s):
Goodwin Donald A, Fuhram L Clifton
|
Jan/Feb 2022
Pg. 18-23
|
Author(s):
Riepl Mike
|
May/Jun 2020
Pg. 188-193
|
Author(s):
Riepl Mike
|
Sep/Oct 2022
Pg. 364-368
|
Author(s):
Riepl Mike
|
Nov/Dec 2020
Pg. 501-508
|
|
Sep/Oct 2009
Pg. 386-389
|
Author(s):
Williams LaVonn A, Fokken Dawn
|
Nov/Dec 2018
Pg. 498-503
|
|
Mar/Apr 2020
Pg. 98-102
|
Author(s):
Riepl Mike
|
Jul/Aug 2022
Pg. 270-274
|
Author(s):
Riepl Mike
|